Drawing for IPSEN BIOPHARMACEUTICALS

USPTO serial 88842199

IPSEN BIOPHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DERBY, KAREN SHEREE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IPSEN BIOPHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 FIFTH AVENUENEW YORK, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments, namely, medical syringes, medical needles and introducers, needles for injection, needles for medical use, needlesACTIVE—
016Printed matter, namely, pamphlets, books, brochures, newsletters, journals, magazines in the fields of science, health, medicine, pharmacy and beautyACTIVE—
040Information services, namely, providing technical information in the field of pharmaceutical manufacturingACTIVE—
041Training services in the fields of science, health, medicine and beauty; education services, namely, arranging and conducting colloquiums, conferences, educational conventions, seminars, educational symposiums in the fields of science, health, medicine, pharmacy and beautyACTIVE—
042Scientific, medical and industrial research services for new products in the fields of health, medicine, pharmacy and beauty; product research and development services for new products in the fields of science, health, medicine, pharmacy and beauty; product design services for chemical products, proprietary medicines, plants and pharmaceutical procedures in production of pharmacologically active substance and preparations, of cosmetics; scientific testing of chemical products, pharmaceutical products, cosmetic products, chemical, biological and bacteriological analysis; design and development of computer hardware and software, all above mentioned services provided for others; providing advice and consulting in connection with scientific researchACTIVE—
044Medical services; providing hygienic and beauty care services for human beings; providing advice and consulting in connection with the medical, pharmaceutical and cosmetic fields; information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, providing information about cosmetic beauty care, and providing medical information; providing a website featuring information in the medical, pharmaceutical and cosmetic fields, namely, information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, information about cosmetic beauty care, and general medical information; medical testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 29, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 29, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 7, 2023EX5GSOU EXTENSION 5 GRANTED—
Dec 7, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 27, 2023EXT5SOU EXTENSION 5 FILED—
Nov 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 23, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 23, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 23, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 8, 2023EX4GSOU EXTENSION 4 GRANTED—
Jun 8, 2023EXT4SOU EXTENSION 4 FILED—
Jun 8, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 14, 2022EX3GSOU EXTENSION 3 GRANTED—
Dec 14, 2022EXT3SOU EXTENSION 3 FILED—
Dec 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 14, 2022EX2GSOU EXTENSION 2 GRANTED—
Jun 14, 2022EXT2SOU EXTENSION 2 FILED—
Jun 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 20, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 6, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 6, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 6, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 30, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 30, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 30, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 30, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 30, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2021EX1GSOU EXTENSION 1 GRANTED—
Nov 5, 2021EXT1SOU EXTENSION 1 FILED—
Nov 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 18, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 18, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2021ALIEASSIGNED TO LIE—
Dec 15, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2020DOCKASSIGNED TO EXAMINER—
Mar 25, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance